Limited time30% off all plans
Get the app
Ask Rezzy/Drug interactions: warfarin, statins, antibiotics — high-yield combinations

Drug interactions: warfarin, statins, antibiotics — high-yield combinations

RezzyRezzy

Managing drug interactions is a massive part of the UKMLA AKT, especially since warfarin and statins are so commonly prescribed in primary care. These interactions often boil down to the Cytochrome P450 (CYP450) system, which is the "metabolic engine" of the liver.

Let's break down the most high-yield combinations you'll likely see in your exam.

1. Warfarin and Antibiotics (The "Bleeding" Combo)

This is a classic exam favorite. Most antibiotics interact with warfarin, but they do it in two main ways:

  • CYP450 Inhibition: Drugs like Clarithromycin, Erythromycin, and Metronidazole inhibit the enzymes that break down warfarin. This leads to a spike in INR and a high risk of bleeding.
  • Gut Flora Alteration: Broad-spectrum antibiotics (like Amoxicillin or Ciprofloxacin) kill the vitamin K-producing bacteria in the gut. Less vitamin K means warfarin becomes even more potent.

Mnemonic: "C-E-M" (Clarithromycin, Erythromycin, Metronidazole) These are the big "INR boosters" you need to watch out for!

2. Statins and Macrolides

Statins (specifically Simvastatin and Atorvastatin) are metabolised by the CYP3A4 enzyme.

  • If a patient is on a statin and starts a macrolide (like Clarithromycin), the statin levels can skyrocket.
  • The Risk: This significantly increases the risk of myopathy and rhabdomyolysis.
  • AKT Tip: Guidelines usually suggest pausing the statin while taking the course of antibiotics.

3. Warfarin and Enzyme Inducers

While some drugs increase warfarin's effect, others "rev up" the liver to clear it faster, making the INR drop (increasing clot risk).

  • Key Inducers: Rifampicin (antibiotic), Phenytoin, and St. John’s Wort.
  • If a patient starts Rifampicin, you'll likely need to increase their warfarin dose significantly.

I'll pull up a comparison table for you that summarizes these interactions clearly, as this is exactly how they like to test it in the AKT.

Interaction PairMechanismClinical OutcomeManagement
Warfarin + Metronidazole/MacrolidesCYP450 InhibitionIncreased INR (Bleeding risk)Monitor INR closely; consider dose reduction
Warfarin + RifampicinCYP450 InductionDecreased INR (Clot risk)Increase Warfarin dose; monitor INR
Statins + ClarithromycinCYP3A4 InhibitionStatin Toxicity (Rhabdomyolysis)Suspend statin during antibiotic course
Warfarin + NSAIDsAntiplatelet effect + GI irritationMajor GI Bleed risk (INR may stay normal!)Avoid combination; use Paracetamol instead

That table covers the "bread and butter" interactions for the AKT. One thing to keep in mind for the exam is that Rifampicin is the outlier among antibiotics—while most increase the INR, Rifampicin is a potent inducer and will decrease it.

To help you lock this in, I've found some relevant lessons and flashcards that focus on these pharmacology "trap" questions.

Those lessons and flashcards should help you nail the CYP450 system. Remember, for the AKT, they love to give you a clinical scenario where a patient is stable on warfarin but then develops a chest infection or a UTI—that's your cue to look for an interaction with the newly prescribed antibiotic!

If you're feeling confident, we could try a quick Synapses game to see if you can group these drugs by their interaction type, or I can pull up some practice questions for you. What do you think?

Setting up chat...